title: Injection-Site Cutaneous Pseudolymphoma Induced by a GM-CSF-Producing Tumor Cell Vaccine.
authors.affiliation: Division of Dermatology, Department of Medicine, Washington University, St Louis, Missouri.
authors.forename: Karl
authors.initials: K
authors.lastname: Staser
authors.affiliation: Department of Pathology and Immunology, Washington University, St Louis, Missouri.
authors.forename: Sabra
authors.initials: S
authors.lastname: Abner
authors.affiliation: Division of Dermatology, Department of Medicine, Washington University, St Louis, Missouri.
authors.forename: Milan
authors.initials: M
authors.lastname: Anadkat
authors.affiliation: Division of Dermatology, Department of Medicine, Washington University, St Louis, Missouri.
authors.forename: Amy
authors.initials: A
authors.lastname: Musiek
authors.affiliation: Division of Dermatology, Department of Medicine, Washington University, St Louis, Missouri2Department of Pathology and Immunology, Washington University, St Louis, Missouri3Dermatopathololgy Center, Washington University, St Louis, Missouri.
authors.forename: András
authors.initials: A
authors.lastname: Schaffer
mesh_terms: D001706:Biopsy; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D019310:Pseudolymphoma / Q000139:chemically induced* / Q000175:diagnosis; D012867:Skin / Q000187:drug effects / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000175:diagnosis; D055815:Young Adult
chemical_list: D019496:Cancer Vaccines; C000593794:GVAX vaccine